Side-by-side comparison of AI visibility scores, market position, and capabilities
Cork commercial building technology (NYSE: JCI) ~$13B pro-forma revenue; new CEO Joakim Weidemanis (March 2025, ex-Danaher), York commercial HVAC + Metasys BMS + OpenBlue AI, residential HVAC sold to Bosch $8.1B.
Johnson Controls International plc is a Cork, Ireland-incorporated building technology company — publicly traded on the New York Stock Exchange (NYSE: JCI) as an S&P 500 Industrials component — providing smart building systems, HVAC equipment, fire detection and suppression, security systems, and building management automation software through approximately 100,000 employees serving commercial, industrial, and institutional buildings in 150 countries. Johnson Controls appointed Joakim Weidemanis as President and CEO effective March 12, 2025, succeeding George R. Oliver who retired after eight years leading the company's transformation from a diversified industrial conglomerate (including auto interiors, automotive batteries, and York HVAC) into a pure-play commercial building technology company. Weidemanis brings 13 years of Danaher experience — most recently as Executive Vice President of Diagnostics and China — applying Danaher Business System operational excellence disciplines to Johnson Controls' building technology platform. A defining 2024 strategic action was the $8.1 billion sale of Johnson Controls' Residential and Light Commercial HVAC business (including the York residential, Coleman, and Champion brands) to Bosch — focusing Johnson Controls entirely on commercial, industrial, and institutional building automation, HVAC, fire, and security. In fiscal year 2024 (ending September 2024), Johnson Controls reported revenue of approximately $22 billion (pre-divestiture), with the commercial and industrial building services generating approximately $12-13 billion in pro-forma revenue after the residential HVAC divestiture.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.